...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
【24h】

Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.

机译:糜蛋白酶作为肥大细胞稳定剂的抑制剂:糜酶对人类肥大细胞活化的贡献。

获取原文
获取原文并翻译 | 示例
           

摘要

There has long been evidence that inhibitors of chymotryptic proteinases can inhibit the degranulation of rodent mast cells, but their actions on human mast cells and the contribution of mast cell chymase itself have received little attention. We investigated the ability of the selective chymase inhibitor Z-Ile-Glu-Pro-Phe-CO(2)Me and other proteinase inhibitors to inhibit chymase and cathepsin G activity, and we examined their potential to modulate the responsiveness of mast cells dispersed from human skin, lung, and tonsil tissues. IgE-dependent histamine release from skin mast cells was inhibited by up to about 80% after preincubation with Z-Ile-Glu-Pro-Phe- CO(2)Me (up to 0.1 microM), 70% with chymostatin (17 microM), and 60% with soybean trypsin inhibitor (0.5 microM). The mast cell-stabilizing properties of chymase inhibitors appeared to be greater for skin mast cells than for those from lung, whereas tonsil mast cells were relatively unresponsive. There were marked differences in the time course of responses to inhibitors, and the effect was dependent on the stimulus, with calcium ionophore-induced histamine release being unaffected. Incubation of dispersed skin, lung, or tonsil cells for up to 45 min with purified chymase failed to induce histamine release, although preincubation of cells with chymase was able to suppress IgE-dependent activation. Chymase could thus contribute to mast cell degranulation and after secretion could provide a feedback mechanism to limit this process. Nevertheless, inhibitors of chymase can be potent mast cell stabilizers, particularly in the skin.
机译:长期以来,有证据表明胰凝乳蛋白酶的抑制剂可以抑制啮齿类动物肥大细胞的脱粒,但是它们对人肥大细胞的作用以及肥大细胞糜酶本身的作用却鲜为人知。我们研究了选择性糜酶抑制剂Z-Ile-Glu-Pro-Phe-CO(2)Me和其他蛋白酶抑制剂抑制糜酶和组织蛋白酶G活性的能力,并研究了它们调节从中分散的肥大细胞反应性的潜力人体皮肤,肺和扁桃体组织。与Z-Ile-Glu-Pro-Phe-CO(2)Me(最高达0.1 microM)预孵育后,皮肤肥大细胞释放的IgE依赖性组胺被抑制高达80%,促凝抑素(17 microM)抑制70% ,以及60%的大豆胰蛋白酶抑制剂(0.5 microM)。糜酶抑制剂的肥大细胞稳定特性对于皮肤肥大细胞似乎比对肺肥大细胞稳定,而扁桃体肥大细胞相对无反应。对抑制剂反应的时间过程存在显着差异,其作用取决于刺激,钙离子载体诱导的组胺释放不受影响。尽管用糜酶预培养细胞能够抑制IgE依赖性激活,但用纯化的糜酶将分散的皮肤,肺或扁桃体细胞温育长达45分钟无法诱导组胺释放。因此,胰酶可以促进肥大细胞脱粒,并且在分泌后可以提供反馈机制来限制该过程。然而,糜蛋白酶抑制剂可以是有效的肥大细胞稳定剂,特别是在皮肤中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号